MedTrace Logo

Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

NCT05924789 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-02-12

No results posted yet for this study

Summary

Currently, there is no Brazilian or Latin American epidemiological data, such as clinical-pathological characteristics, standard treatments and outcomes of gastric cancer and pancreatic cancer in the region. The study aims to create a Latin American multicenter database to analyze epidemiological, clinical, and pathological data, treatments, outcomes, and biological information from patients with gastric and pancreatic cancer.

Conditions

Interventions

OTHER

Observational study

This is an observational study; patients will not be exposed to clinical interventions different from those belonging to the standard of care.

Sponsors & Collaborators

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Grupo Argentino de Investigación Clínica en Oncología (GAICO)

    collaborator UNKNOWN

  • Latin American Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Renata D´Alpino Peixoto · Latin American Cooperative Oncology Group

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-11
Primary Completion
2024-09-24
Completion
2024-09-24

Countries

  • Argentina
  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05924789 on ClinicalTrials.gov